Kyntra Bio, Inc. (KYNB) — Cash Flow Quality Index
Kyntra Bio, Inc. (KYNB) has a Cash Flow Quality Index of 0.59x as of March 2025. Operating cash flow of $2.72 Million is below net income of $4.64 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore KYNB strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Kyntra Bio, Inc. Cash Flow Quality Index (2025–2025)
Historical Cash Flow Quality Index for Kyntra Bio, Inc. across 1 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check KYNB tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for Kyntra Bio, Inc. (2025–2025)
Year-by-year earnings quality comparison for Kyntra Bio, Inc.. For live market cap and the full company financial profile, see Kyntra Bio, Inc. market capitalisation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | -0.03x | $-4.77 Million | $183.45 Million | — |